Clinical Trial Update: A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for COMPANION-002 evaluating CTX-009 in combination with Paclitaxel in adults with unresectable or metastatic biliary tract cancers; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ampullary Cancer
• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• CTX-009 (CTX-009)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Compass Therapeutics | Conditions: Biliary Tract Cancer, Cholangiocarcinoma | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING